ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, in vitro evaluation, and docking studies on ibuprofen derived 1,3,4-oxadiazole derivatives as dual α-glucosidase and urease inhibitors

Daud, Saima; Abid, Obaid-ur-Rahman*; Sardar, Asma; Shah, Basit Ali; Rafiq, Muhammad; Wadood, Abdul; Ghufran, Mehreen; Rehman, Wajid; Zain-ul-Wahab; Iftikhar, Fatima; Sultana, Rifhat; Daud, Habiba; Niaz, Basit*
MEDICINAL CHEMISTRY RESEARCH2022-2DOI: 10.1007/s00044-021-02814-6
16被引5阅读
引用收藏
分享

摘要

Present study aimed at the discovery of new non-sugar alpha-glucosidase inhibitors includes synthesis of a series of 1,3,4-oxadiazole based Schiff base derivatives of ibuprofen. Initially oxadiazoles from ibuprofen were synthesized by treating ibuprofen hydrazide with carbon disulfide. Oxadiazoles upon treatment with different substituted phenacyl bromides give acylated 1,3,4-oxadizole derivatives 6(a-e) which further react with amines to give 1,3,4-oxadiazole based Schiff base derivatives of ibuprofen 7(a-o). The synthesized ibuprofen derivatives were characterized by H-1 NMR, C-13 NMR and HRMS (EI). These derivatives were evaluated in vitro for their alpha-glucosidase and urease inhibitory activity. In case of alpha-glucosidase enzyme, all the synthesized derivatives showed potent inhibition in comparison to standard acarbose and the most potent amongst these are the compounds 7o and 7b having IC50 value 16.01 +/- 1.27 mu M and 39.06 +/- 0.27 mu M, respectively. In case of urease enzyme, the synthesized derivatives showed varying degree of inhibitory potential, however, potent inhibition was shown by 6d (IC50 = 9.36 +/- 1.02 mu M), 6c (IC50 = 17.65 +/- 1.03 mu M), 7o (IC50 = 18.29 +/- 1.26 mu M), 6a (IC50 = 19.52 +/- 1.25 mu M) and 7j (IC50 = 19.63 +/- 1.08 mu M). The molecular docking was performed in order to check binding interactions between the synthesized derivatives and the enzymes. @@@ [GRAPHICS] @@@ .

学科与关键词

关键词
Ibuprofen1,3,4-Oxadiazole Schiff basesalpha-GlucosidaseUrease inhibition activity and molecular docking studies
相关
加载中…
  • Exploring ibuprofen derivatives as α-glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies
    Daud, Saima; Abid, Obaid-ur-Rahman*; Sardar, Asma; Abdullah, Shawana; Shahid, Wardah; Ashraf, Muhammad*; Ejaz, Syeda Abida; Saeed, Amna; Shah, Basit Ali; Niaz, Basit*Archiv der Pharmazie, 2022, 355(8): e2200013.被引 4
  • In vitro evaluation of novel mefenamic acid derivatives as potential a-glucosidase and urease inhibitors: Design, synthesis, in silico and cytotoxic studies
    Daud, Saima; Abid, Obaid-ur-Rahman*; Rehman, Wajid*; Niaz, Maryam; Sardar, Asma; Rasheed, Liaqat; Niaz, Basit; Shah, Basit Ali; Alotaibi, Hadil Faris; Obaidullah, Ahmad J.; Alanazi, Mohammed M.Journal of Saudi Chemical Society, 2023, 27(4): 101680.
  • Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies
    Mohammad Sadegh, Asgari; Maryam, Mohammadi-Khanaposhtani; Zeinab, Sharafi; Mohammad Ali, Faramarzi; Hossein, Rastegar; Ensieh, Nasli Esfahani; Fatemeh, Bandarian; Parviz, Ranjbar Rashidi; Rahmatollah, Rahimi; Mahmood, Biglar; Mohammad, Mahdavi; Bagher, LarijaniMOLECULAR DIVERSITY, 2020.
查看全部 →

发表信息

论文状态
公开发表
期刊
MEDICINAL CHEMISTRY RESEARCH
发表日期
2022-02
卷期
第 31 卷, 第 2 期
页码
316-336
DOI
10.1007/s00044-021-02814-6
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • D

    Daud, Saima (第一作者)

  • A

    Abid, Obaid-ur-Rahman (通讯)

查看全部 13 位作者收起作者
  • S

    Sardar, Asma

  • S

    Shah, Basit Ali

  • R

    Rafiq, Muhammad

  • W

    Wadood, Abdul

  • G

    Ghufran, Mehreen

  • R

    Rehman, Wajid

  • Z

    Zain-ul-Wahab

  • I

    Iftikhar, Fatima

  • S

    Sultana, Rifhat

  • D

    Daud, Habiba

  • N

    Niaz, Basit (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417